---
title: "JOINN Laboratories sets 2025 AGM to approve profit distribution and new share incentive plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286096985.md"
description: "JOINN Laboratories (China) Co., Ltd. has scheduled its 2025 annual general meeting for June 4, 2026, in Beijing. Shareholders will review the annual report, profit distribution plan, and new remuneration rules for directors. The meeting will also address the appointment of a new non-executive director and auditor renewals. Key dates for share registration and eligibility for profit distribution will be clarified. The latest analyst rating for JOINN Laboratories stock (HK:6127) is a Hold with a price target of HK$16.30."
datetime: "2026-05-12T11:25:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286096985.md)
  - [en](https://longbridge.com/en/news/286096985.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286096985.md)
---

# JOINN Laboratories sets 2025 AGM to approve profit distribution and new share incentive plan

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) just unveiled an update.

JOINN Laboratories (China) Co., Ltd. has convened its 2025 annual general meeting for June 4, 2026 in Beijing, where shareholders will review the 2025 annual report, board work report and a proposed profit distribution plan. The meeting will also consider new remuneration rules for directors and senior management, set director pay, appoint a new non-executive director, and renew the company’s auditors.

Shareholders will vote on amendments to the articles of association and meeting procedures, and on a 2026 Restricted A Share Incentive Scheme along with its assessment measures and related board authorizations. The company has also set specific share register closure periods to determine eligibility for attending the AGM and receiving the 2025 profit distribution, clarifying key dates for investors seeking voting rights and dividend entitlement.

The most recent analyst rating on (HK:6127) stock is a Hold with a HK$16.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.

**More about JOINN Laboratories (China) Co., Ltd. Class H**

JOINN Laboratories (China) Co., Ltd. is a Chinese contract research organization focused on preclinical and related laboratory services for the pharmaceutical and biotech industries. The company is listed in Hong Kong as a Class H share issuer and serves both domestic and international clients seeking regulated non-clinical testing and development support.

**Average Trading Volume:** 4,251,004

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$30.42B

Find detailed analytics on 6127 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [06127.HK](https://longbridge.com/en/quote/06127.HK.md)
- [603127.CN](https://longbridge.com/en/quote/603127.CN.md)

## Related News & Research

- [JOINN Laboratories Grants New Three-Year H-Share Awards to Management](https://longbridge.com/en/news/284780987.md)
- [The Trading Awards: Voting is open until 19 May](https://longbridge.com/en/news/286793607.md)
- [Artivion Completes Acquisition of Endospan Ltd. | AORT Stock News](https://longbridge.com/en/news/286758893.md)
- [Stocks in Play: Interfor Corporation](https://longbridge.com/en/news/286585579.md)
- [ARTRARI ONE CAPITAL CORP. REPORTS ON VOTING RESULTS FROM THE 2026 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS](https://longbridge.com/en/news/286606232.md)